Testing SupportGroove: a Novel Mhealth Intervention for Couples Coping with Spinal Cord Injury

February 12, 2025 updated by: Alexandra Terrill, University of Utah
The purpose of this study is to test the preliminary effects of an 8-week mobile application-based program (SupportGroove) developed for persons with spinal cord injury and their romantic partners.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Eligible couples who provide informed consent will be enrolled in the study and will be randomized to either immediately start the 8-week SupportGroove program or be waitlisted for 8-weeks before starting the program. While actively participating in the program, couples will use the app to engage in daily "quests" (positive psychology-based activities to be completed on their own or as a couple). Both partners in the participating couple complete self-report assessments at baseline (0 weeks), 8 weeks, 16 weeks, and 28 weeks.

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Utah
      • Salt Lake City, Utah, United States, 84108
        • University of Utah
    • Virginia
      • Richmond, Virginia, United States, 23249
        • McGuire Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • cohabitating romantic couples where one partner has sustained a spinal cord injury at least 3 months prior to enrolling in the study
  • be able to read and understand printed English instructions
  • have a smartphone, tablet, or personal computer with internet access

Exclusion Criteria:

  • the partner has a spinal cord injury or other major neurological condition
  • either partner is unable to read and understand printed English instructions
  • either partner does not consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SupportGroove
8-week intervention that is remotely delivered through a mobile app, consisting of daily "quests" (positive psychology-based activities) completed individually and as a couple.
Behavioral: SupportGroove
An app-delivered program consisting of positive psychology-based activities, such as expressing gratitude, finding meaning, savoring, and fostering connections. Participants complete daily "quests" suggested through the app, some of which are completed on their own, and some with their partner.
No Intervention: Waitlist control
Participants will be waitlisted for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal Cord Injury Quality of Life (SCI-QOL) Resilience-Short Form
Time Frame: Baseline (0 weeks)
10-items assessing state resilience; rated from 1-5 (never-always); score range from 19-50, higher score = more resilient /better outcome
Baseline (0 weeks)
Spinal Cord Injury Quality of Life (SCI-QOL) Resilience-Short Form
Time Frame: 8 weeks
10-items assessing state resilience; rated from 1-5 (never-always); score range from 19-50, higher score = more resilient /better outcome
8 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Resilience-Short Form
Time Frame: 16 weeks
10-items assessing state resilience; rated from 1-5 (never-always); score range from 19-50, higher score = more resilient /better outcome
16 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Resilience-Short Form
Time Frame: 28 weeks
10-items assessing state resilience; rated from 1-5 (never-always); score range from 19-50, higher score = more resilient /better outcome
28 weeks
Patient Health Questionnaire-9
Time Frame: 0 weeks
9-item depression measure; rated from 0-3 (not at all-nearly every day); score range from 0-27, higher scores = more depressed /worse outcome
0 weeks
Patient Health Questionnaire-9
Time Frame: 8 weeks
9-item depression measure; rated from 0-3 (not at all-nearly every day); score range from 0-27, higher scores = more depressed /worse outcome
8 weeks
Patient Health Questionnaire-9
Time Frame: 16 weeks
9-item depression measure; rated from 0-3 (not at all-nearly every day); score range from 0-27, higher scores = more depressed /worse outcome
16 weeks
Patient Health Questionnaire-9
Time Frame: 28 weeks
9-item depression measure; rated from 0-3 (not at all-nearly every day); score range from 0-27, higher scores = more depressed /worse outcome
28 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Positive Affect and Wellbeing
Time Frame: 0 weeks
10-items assessing aspects of well-being; rated from 1-5 (never-always); score range from 10-50, higher score = greater well-being /better outcome
0 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Positive Affect and Wellbeing
Time Frame: 8 weeks
10-items assessing aspects of well-being; rated from 1-5 (never-always); score range from 10-50, higher score = greater well-being /better outcome
8 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Positive Affect and Wellbeing
Time Frame: 16 weeks
10-items assessing aspects of well-being; rated from 1-5 (never-always); score range from 10-50, higher score = greater well-being /better outcome
16 weeks
Spinal Cord Injury Quality of Life (SCI-QOL) Positive Affect and Wellbeing
Time Frame: 28 weeks
10-items assessing aspects of well-being; rated from 1-5 (never-always); score range from 10-50, higher score = greater well-being /better outcome
28 weeks
Revised Dyadic Adjustment Scale
Time Frame: 0 weeks
14-items assessing couple satisfaction and how each partner within the couple perceives their relationship; rated on a scale from 0-5; score range from 0-70, higher scores = better adjustment/greater relationship satisfaction /better outcome
0 weeks
Revised Dyadic Adjustment Scale
Time Frame: 8 weeks
14-items assessing couple satisfaction and how each partner within the couple perceives their relationship; rated on a scale from 0-5; score range from 0-70, higher scores = better adjustment/greater relationship satisfaction /better outcome
8 weeks
Revised Dyadic Adjustment Scale
Time Frame: 16 weeks
14-items assessing couple satisfaction and how each partner within the couple perceives their relationship; rated on a scale from 0-5; score range from 0-70, higher scores = better adjustment/greater relationship satisfaction /better outcome
16 weeks
Revised Dyadic Adjustment Scale
Time Frame: 28 weeks
14-items assessing couple satisfaction and how each partner within the couple perceives their relationship; rated on a scale from 0-5; score range from 0-70, higher scores = better adjustment/greater relationship satisfaction /better outcome
28 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Utah

Collaborators

McGuire Research Institute

Investigators

  • Principal Investigator: Alexandra L Terrill, PhD, University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2022

Primary Completion (Actual)

December 30, 2024

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

August 31, 2022

First Submitted That Met QC Criteria

August 31, 2022

First Posted (Actual)

September 2, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 12, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 720484

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe